The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model MiceTakayasu Ideta, Masahito Shimizu|International Journal of Molecular Sciences|2015Cited by 57